UK Sexually Transmitted Diseases (STD) Diagnostics Market Share 2022: Trends, Key Players, Industry Analysis and Forecast 2022-2028

UK STD diagnostics market is growing at a CAGR of around 8.6% during the forecast period. UK has one of the finest healthcare systems in the EU region, which enables it to provide quality healthcare to the individuals. UK is one of the major countries in the European region. There are many factors such as rising STDs, and growth of healthcare infrastructure, which augment the UK STD diagnostics market. According to Index of Economic Freedom, the population of the UK in 2018 is estimated to be around 65.6 million, with the top personal income tax rate being 45%, and the top corporate tax rate with a 20% decrease.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-sexually-transmitted-disease-market

Further, demand for high-skill and high-technology jobs outpaces the number of work-ready graduates, which the educational system can produce. The UK with few price controls, regulates the rates for most utilities, and partly controls the price of prescription drugs. This increases the market players’ business in the region. The overall net national income is also augmented in this region, raising the power of public to spend on their health, diagnostic kits, rapid test kits, point of care devices and others.

The companies which are contributing significantly in the UK STD diagnostics market include Abbott Laboratories, AbbVie Inc., Becton, Dickinson and Co., Biocartis NV, Bio-Rad Laboratories, Inc., Danaher Corp., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific, Inc. among others. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

UK STD Diagnostics Market Segmentation

By Disease Type

  • Chlamydia
  • Syphilis
  • Gonorrhea
  • Herpes Simplex Virus (HSV)
  • Human Papilloma Virus (HPV)
  • Human Immunodeficiency Virus (HIV)
  • Others

By Product

  • Laboratory Testing Devices
  • Point-of-Care (POC) Testing Devices

By End-user

  • Hospitals and Clinics
  • Diagnostic Centers
  • Homecare

A full report of UK Sexually Transmitted Diseases (STD) Diagnostics Market available @ https://www.omrglobal.com/industry-reports/uk-sexually-transmitted-disease-market

Company Profiles

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Eli Lilly and Co.
  • Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.